A Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Investigate the Safety, Tolerability & Pharmacokinetics of Single Oral Escalating Doses of GW572016 Ditosylate Monohydrate in Healthy Male Volunteers

Grants and Contracts Details

StatusFinished
Effective start/end date1/6/011/2/02

Funding

  • Glaxo Wellcome: $386,336.00